Trial Profile
A Phase II Trial of BBR 3464 as First Line Treatment in Patients With Inoperable, Locally Advanced or Metastatic Adenocarcinoma of the Pancreas
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2005
Price :
$35
*
At a glance
- Drugs BBR 3464 (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 19 Sep 2005 New trial record.